TimeScale Financial’s Biogen BIIB Stock Holding History

TimeScale Financial’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$1.14K	Sell	4 -100	-96%	-$29.8K	﹤0.01%	540
2023 Q1	$28.9K	Hold	104	–	–	0.01%	250
2022 Q4	$27.8K	Hold	104	–	–	0.01%	201
2022 Q3	$28K	Hold	104	–	–	0.01%	199
2022 Q2	$21K	Hold	104	–	–	0.01%	219
2022 Q1	$22K	Hold	104	–	–	0.01%	229
2021 Q4	$25K	Buy	104 +4	+4%	+$1.03K	0.01%	223
2021 Q3	$28K	Sell	100 -69	-41%	-$22.6K	0.01%	214
2021 Q2	$59K	Buy	169 +69	+69%	+$20.9K	0.01%	164
2021 Q1	$28K	Buy	+100	New	+$27K	0.01%	231
2020 Q2	–	Sell	-217	Closed	-$68K	–	442
2020 Q1	$68K	Hold	217	–	–	0.02%	112
2019 Q4	$64K	Buy	+217	New	+$60.2K	0.02%	150
2019 Q3	–	Sell	-82	Closed	-$19K	–	498
2019 Q2	$19K	Buy	+82	New	+$18.9K	0.01%	290

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

TimeScale Financial's BIIB Position: Q2 2023 in Review

TimeScale Financial reduced its Biogen (BIIB) stake by 96% in Q2 2023, selling an estimated $29.8K and leaving 4 shares worth $1.14K. The position accounts for ﹤0.01% of the portfolio, ranked #540.

TimeScale Financial first reported a position in BIIB in Q2 2019 and has held it in 13 quarters since. The position peaked at $68K in Q1 2020. 1,008 funds tracked by Wall St. Rank hold BIIB as of Q2 2023.

TimeScale Financial held 4 shares of Biogen worth $1.14K as of Q2 2023.
TimeScale Financial sold 100 Biogen shares in Q2 2023, an estimated $29.8K.
Biogen made up ﹤0.01% of TimeScale Financial's portfolio in Q2 2023, its #540 holding.
TimeScale Financial first reported a position in Biogen in Q2 2019 and has held it in 13 quarters since.
TimeScale Financial's Biogen position peaked at $68K in Q1 2020.
1,008 funds tracked by Wall St. Rank held Biogen as of Q2 2023.

Based on TimeScale Financial's 13F filing for Q2 2023, filed 27 Jul 2023.